Amyloid Precursor Protein (APP) Regulates Gliogenesis and Neurogenesis of Human Neural Stem Cells by Several Signaling Pathways.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Aug 2023
Historique:
received: 14 07 2023
revised: 11 08 2023
accepted: 18 08 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Numerous studies have focused on the pathophysiological role of amyloid precursor protein (APP) because the proteolytic processing of APP to β-amyloid (Aβ) peptide is a central event in Alzheimer's disease (AD). However, many authors consider that alterations in the physiological functions of APP are likely to play a key role in AD. Previous studies in our laboratory revealed that APP plays an important role in the differentiation of human neural stem cells (hNSCs), favoring glial differentiation (gliogenesis) and preventing their differentiation toward a neuronal phenotype (neurogenesis). In the present study, we have evaluated the effects of APP overexpression in hNSCs at a global gene level by a transcriptomic analysis using the massive RNA sequencing (RNA-seq) technology. Specifically, we have focused on differentially expressed genes that are related to neuronal and glial differentiation processes, as well as on groups of differentially expressed genes associated with different signaling pathways, in order to find a possible interaction between them and APP. Our data indicate a differential expression in genes related to Notch, Wnt, PI3K-AKT, and JAK-STAT signaling, among others. Knowledge of APP biological functions, as well as the possible signaling pathways that could be related to this protein, are essential to advance our understanding of AD.

Identifiants

pubmed: 37629148
pii: ijms241612964
doi: 10.3390/ijms241612964
pmc: PMC10455174
pii:
doi:

Substances chimiques

Amyloid beta-Protein Precursor 0
Phosphatidylinositol 3-Kinases EC 2.7.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Dev Cell. 2015 Feb 23;32(4):502-15
pubmed: 25710536
Development. 2004 May;131(9):2173-81
pubmed: 15073156
Pharmacol Ther. 2022 Jul;235:108122
pubmed: 35114285
Biochem Biophys Res Commun. 2014 May 9;447(3):394-9
pubmed: 24727450
Neurol Ther. 2017 Jul;6(Suppl 1):69-81
pubmed: 28733957
J Neurosci Res. 2005 Oct 1;82(1):32-42
pubmed: 16118793
Neurosci Lett. 2018 Oct 15;685:190-195
pubmed: 30176342
Acta Neuropathol. 2020 Oct;140(4):417-447
pubmed: 32728795
Neurosci Bull. 2023 Aug;39(8):1289-1308
pubmed: 36443453
J Biol Chem. 2011 Jul 8;286(27):24264-74
pubmed: 21606494
Front Cell Dev Biol. 2022 Jul 26;10:969547
pubmed: 35959488
J Alzheimers Dis. 2007 Nov;12(3):229-40
pubmed: 18057556
Neurotox Res. 2010 Nov;18(3-4):328-38
pubmed: 20309664
Database (Oxford). 2019 Jan 1;2019:
pubmed: 30951143
Neurobiol Aging. 2010 Jan;31(1):58-73
pubmed: 18403052
Development. 2014 Jul;141(13):2543-8
pubmed: 24961795
Exp Cell Res. 2004 Apr 1;294(2):559-70
pubmed: 15023542
Nat Cell Biol. 2008 Mar;10(3):283-94
pubmed: 18278038
Biochim Biophys Acta. 2012 Aug;1823(8):1233-41
pubmed: 22613765
Development. 2003 Apr;130(7):1391-402
pubmed: 12588854
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
Dev Neurobiol. 2012 Jul;72(7):1068-84
pubmed: 22489086
Trends Pharmacol Sci. 2016 May;37(5):390-411
pubmed: 26837733
Development. 2021 Oct 15;148(20):
pubmed: 34557919
Bioinformatics. 2017 Jun 9;33(19):3137-3139
pubmed: 28605449
Development. 2002 Jan;129(2):373-85
pubmed: 11807030
Nat Commun. 2023 Jan 16;14(1):239
pubmed: 36646699
Nucleic Acids Res. 2012 Jan;40(Database issue):D109-14
pubmed: 22080510
FASEB J. 2014 Jan;28(1):195-205
pubmed: 24036883
Mech Dev. 2000 Jun;94(1-2):233-6
pubmed: 10842078
Neurotherapeutics. 2015 Jan;12(1):3-11
pubmed: 25371168
Sci Rep. 2020 Jun 23;10(1):10127
pubmed: 32576936
Int J Mol Sci. 2022 May 22;23(10):
pubmed: 35628629
Int J Mol Sci. 2021 Sep 02;22(17):
pubmed: 34502444
Curr Alzheimer Res. 2021;18(10):772-786
pubmed: 34879801
Nat Rev Neurosci. 2017 May;18(5):281-298
pubmed: 28360418
Mol Neurobiol. 2019 Feb;56(2):1248-1261
pubmed: 29881946
J Neurochem. 2014 Jun;129(5):756-69
pubmed: 24517464
Curr Protoc. 2021 Mar;1(3):e90
pubmed: 33780170
Nucleic Acids Res. 2019 Jan 8;47(D1):D721-D728
pubmed: 30289549
Exp Neurol. 2000 Jan;161(1):67-84
pubmed: 10683274
Development. 2016 Sep 1;143(17):3050-60
pubmed: 27578176
EMBO J. 2016 Oct 17;35(20):2213-2222
pubmed: 27572463
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Transl Psychiatry. 2018 Sep 20;8(1):179
pubmed: 30232325
Acta Neuropathol. 2015 Jan;129(1):1-19
pubmed: 25287911
J Biol Chem. 2009 Aug 28;284(35):23806-17
pubmed: 19542221
Curr Protoc Bioinformatics. 2015 Sep 03;51:11.14.1-11.14.19
pubmed: 26334920
Elife. 2021 Sep 09;10:
pubmed: 34515635
Science. 2020 Mar 13;367(6483):1230-1234
pubmed: 32165583
Brain Behav Immun. 2019 Jul;79:159-173
pubmed: 30763768
J Biol Chem. 2011 May 27;286(21):18414-25
pubmed: 21460223
J Biol Chem. 2013 Jun 28;288(26):18853-62
pubmed: 23671283
Mol Neurobiol. 2019 Jun;56(6):4023-4036
pubmed: 30259399
Cell Adh Migr. 2011 Jul-Aug;5(4):280-92
pubmed: 21785276
Front Neurosci. 2021 Feb 25;15:628983
pubmed: 33716653
Cells. 2021 May 10;10(5):
pubmed: 34068607
Dev Neurosci. 2003 Mar-Aug;25(2-4):162-72
pubmed: 12966214
Mol Cell Neurosci. 2012 Aug;51(1-2):43-52
pubmed: 22884903
Cells. 2021 Aug 10;10(8):
pubmed: 34440814
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
J Neurosci. 2007 Dec 26;27(52):14459-69
pubmed: 18160654
Cell Death Dis. 2015 Feb 19;6:e1651
pubmed: 25695604
J Neurochem. 2017 Oct;143(1):11-29
pubmed: 28677143
IUBMB Life. 2010 Aug;62(8):618-23
pubmed: 20681026
Mol Brain. 2022 Jan 3;15(1):5
pubmed: 34980189
Eur J Pharmacol. 2011 Jan 10;650(1):18-27
pubmed: 20883690

Auteurs

Raquel Coronel (R)

Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Departamento de Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Alcalá de Henares, 28871 Madrid, Spain.

Adela Bernabeu-Zornoza (A)

Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

Charlotte Palmer (C)

Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

Rosa González-Sastre (R)

Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Unidad de Biología Computacional, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

Andreea Rosca (A)

Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

Patricia Mateos-Martínez (P)

Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

Victoria López-Alonso (V)

Unidad de Biología Computacional, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

Isabel Liste (I)

Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH